Viyash Scientific Limited Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by Prasad Lad, was filed 10 Nov 2021.
Viyash Scientific Limited: what insiders have been doing
Every trade that managers of Viyash Scientific Limited disclose to SEBI (PIT + SAST) is tracked on this page. The company sits in the Health Care sector. No insider at Viyash Scientific Limited has published a filing in the past twelve months. The most recent one dates from 26 December 2023.
Our records for Viyash Scientific Limited go back to 2021, with 1 purchase and 45 sales on the open market in total.
In the same sector, recent insider purchases at Dynavox Group AB and Vetoquinol SA also feature in our signals. Source: insider filings from SEBI (PIT + SAST). Past trades are no guide to future returns.
Since the insiders bought
- -48.0%Entry ₹184.05 · Close at T+365 ₹95.70
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Viyash Scientific Limited Strong Buy (bullish), based on 4 analysts. Average price target: ₹326.00.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 550,000 shares@ ₹115.1151100.0% of flowEquity SharesSEBI:caf57690d94b58685b89365dd502a0a3b69a6a95
- 52,634 shares@ ₹136.482.9% of flowEquity SharesSEBI:d25f07be11c692ee05b624f7c9fa59e0bf8c19d3
- 103,498 shares@ ₹138.445.7% of flowEquity SharesSEBI:c37fe5c994e3116d99cab599aabbc68623115cc5
- 291,476 shares@ ₹133.9515.7% of flowEquity SharesSEBI:6a13cd9f3be182383a4728ed5dd85549a6bd07f5
- 98,023 shares@ ₹130.13195.1% of flowEquity SharesSEBI:87feb1ade728a9dad3e8ef85692b90c8d972d5f8
- 300,000 shares@ ₹133.0316.0% of flowEquity SharesSEBI:96f68a20e2722ecd0eca336d7e9334346ab037e7
- 66,421 shares@ ₹124.163.3% of flowEquity SharesSEBI:cc3f7773552102551f123f08305bcb4e6832a8bb
- 286,500 shares@ ₹124.1214.3% of flowEquity SharesSEBI:be1163425fffe9f76c57f806d8e1fefdfd2f21e2
- 6,317 shares@ ₹124.07990.3% of flowEquity SharesSEBI:5bc45bf04d29521446042b14529ed1e97b16c6a4
- 54,230 shares@ ₹125.202.7% of flowEquity SharesSEBI:6318d6f05fbbdefbdab3d840a8f9c2b0231c8a90
- 20,000 shares@ ₹130.301.0% of flowEquity SharesSEBI:321d106f4af4bee8b31afb60c6056893adc2cda9
- 17,000 shares@ ₹130.350.9% of flowEquity SharesSEBI:3aeba18bb48babbadbf549f6b359d2aa864d0c96
- 52,327 shares@ ₹134.492.8% of flowEquity SharesSEBI:097aac615d54c55dacf5f182d4eb3f808ac97769
- 100,000 shares@ ₹135.585.4% of flowEquity SharesSEBI:23e8fbb1ea50d14880b7caf942b7910370770397
- 70,949 shares@ ₹145.184.1% of flowEquity SharesSEBI:c54342380b1eb232301bcafc1c512c9bfe127892
- 20,000 shares@ ₹145.0026.9% of flowEquity SharesSEBI:356de641fa9f46649149d72b3c26cf12caa9e484
- 128,787 shares@ ₹147.727.6% of flowEquity SharesSEBI:2b2feb89299aec3024039d00e221262577310d3d
- 18,006 shares@ ₹154.041.1% of flowEquity SharesSEBI:44843a33cb8ba2848841dbe05d2cb5c710250573
- 20,000 shares@ ₹159.355829.3% of flowEquity SharesSEBI:08554500ecb280e0c126c603c3c9f2d36444917e
- 25,000 shares@ ₹159.182936.6% of flowEquity SharesSEBI:0ba010172a4b74b10e37125c5534d9566fe891d0
- 150,000 shares@ ₹159.809.5% of flowEquity SharesSEBI:2e856ce862ea8bc843a31600abcf302493174607
- 5,000 shares@ ₹154.857.1% of flowEquity SharesSEBI:688f4386a3b05013a25430ada06dcee3036123bb
- 60,000 shares@ ₹158.47100.0% of flowEquity SharesSEBI:4e1202376e30d7267ad4a1797a9689453d2ee5ad
- 11,260 shares@ ₹160.9288100.0% of flowEquity SharesSEBI:09b550d1ef73c82c57b7b43011fa52b03144a0a4
- 10,000 shares@ ₹161.2628.5% of flowEquity SharesSEBI:f35ec81e74a376a9be9122aa425be3ec45fb6cac
25 of 50 declarations
About Viyash Scientific Limited
Viyash Scientific Limited is a company operating in the healthcare and pharmaceutical sector. It is listed on the XBOM.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
